SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-126167
Filing Date
2015-04-10
Accepted
2015-04-10 16:33:00
Documents
4
Period of Report
2015-04-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d907678d8k.htm 8-K 15293
2 EX-10.1 d907678dex101.htm EX-10.1 175794
3 EX-10.2 d907678dex102.htm EX-10.2 27262
4 EX-10.3 d907678dex103.htm EX-10.3 58757
  Complete submission text file 0001193125-15-126167.txt   278395
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 15764783
SIC: 2834 Pharmaceutical Preparations